Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Markman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep Tabernero
Current Clinical Pharmacology|March 22, 2012
Application of monoclonal antibodies as cancer therapy in solid tumorsRodrigo Dienstmann, Ben Markman, Josep Tabernero
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapyCésar Serrano, Ben Markman, Josep Tabernero
Oncotarget|February 15, 2011
Targeting the PI3K/Akt/mTOR pathway--beyond rapalogsBen Markman, Rodrigo Dienstmann, Josep Tabernero
Current Pharmaceutical Design|September 15, 2012
PI3K pathway inhibitors: better not left aloneBen Markman, Jessica J Tao, Maurizio Scaltriti
Immunotherapy|July 20, 2010
New trends in epidermal growth factor receptor-directed monoclonal antibodiesBen Markman, Jaume Capdevila, Elena Elez, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 8, 2011
Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2Rodrigo Dienstmann, Jordi Rodon, Ben Markman, et al.
Advances in Clinical Chemistry|September 23, 2010
EGFR and KRAS in colorectal cancerBen Markman, Francisco Javier Ramos, Jaume Capdevila, et al.
Critical Reviews in Oncology/Hematology|June 28, 2020
Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting - A systematic review and meta-analysisAjay Raghunath, Sahan D Chandrasekara, Shane N Anthony, et al.
Cancer Treatment and Research Communications|April 29, 2025
Durvalumab consolidation after chemoradiotherapy in unresectable stage III non-small cell lung cancer: A real-world experience from the Australian subset of PACIFIC-RBen Markman, Steven Kao, Nick Pavlakis, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep Tabernero
Current Clinical Pharmacology|March 22, 2012
Application of monoclonal antibodies as cancer therapy in solid tumorsRodrigo Dienstmann, Ben Markman, Josep Tabernero
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapyCésar Serrano, Ben Markman, Josep Tabernero
Oncotarget|February 15, 2011
Targeting the PI3K/Akt/mTOR pathway--beyond rapalogsBen Markman, Rodrigo Dienstmann, Josep Tabernero
Current Pharmaceutical Design|September 15, 2012
PI3K pathway inhibitors: better not left aloneBen Markman, Jessica J Tao, Maurizio Scaltriti
Immunotherapy|July 20, 2010
New trends in epidermal growth factor receptor-directed monoclonal antibodiesBen Markman, Jaume Capdevila, Elena Elez, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 8, 2011
Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2Rodrigo Dienstmann, Jordi Rodon, Ben Markman, et al.
Advances in Clinical Chemistry|September 23, 2010
EGFR and KRAS in colorectal cancerBen Markman, Francisco Javier Ramos, Jaume Capdevila, et al.
Critical Reviews in Oncology/Hematology|June 28, 2020
Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting - A systematic review and meta-analysisAjay Raghunath, Sahan D Chandrasekara, Shane N Anthony, et al.
Cancer Treatment and Research Communications|April 29, 2025
Durvalumab consolidation after chemoradiotherapy in unresectable stage III non-small cell lung cancer: A real-world experience from the Australian subset of PACIFIC-RBen Markman, Steven Kao, Nick Pavlakis, et al.
Pageof 5